Related Experiment Video

Updated: Aug 16, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

[Erectile dysfunction in the case of cardiovascular disease]

P Desvaux1

  • 1Andrologue - sexologue, Hôpital Cochin, Paris.

Presse Medicale (Paris, France : 1983)
|September 15, 2005
PubMed

Insights

Erectile dysfunction is common in heart disease patients and may signal arterial issues. Intracavernous prostaglandin E1 injections offer a safe and effective treatment for erectile dysfunction in cardiac populations, with no reported drug interactions.

Area of Science:

  • Cardiology
  • Urology
  • Vascular Health

Context:

  • Erectile dysfunction (ED) is highly prevalent in patients with cardiovascular disease (CVD).
  • ED can serve as an early indicator of subclinical atherosclerotic disease.
  • Managing ED in cardiac patients is crucial for overall well-being.

Purpose:

  • To evaluate the efficacy and safety of intracavernous prostaglandin E1 (PGE1) injections for treating ED in patients with heart disease.
  • To assess potential drug interactions between PGE1 and common cardiac medications.
  • To determine the impact of ED management on patient adherence to cardiovascular treatments.

Summary:

  • Intracavernous PGE1 injections were found to be an effective and safe second-line therapy for ED in cardiac patients, irrespective of ED etiology.
  • No adverse drug interactions were reported with concurrent use of standard cardiovascular therapies, including nitrate derivatives.
  • Successful management of ED improved patient adherence to prescribed cardiac treatments.

Impact:

  • Provides a reliable and safe treatment option for ED in a high-risk population.
  • Highlights the importance of addressing ED as part of comprehensive cardiovascular care.
  • Suggests that improved sexual function can positively influence treatment compliance in patients with heart disease.

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...